These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 1718101)
21. Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis. Vrushabhendrappa ; Singh AK; Balakrishna K; Sripathy MH; Batra HV Vaccine; 2014 Sep; 32(43):5600-6. PubMed ID: 25131740 [TBL] [Abstract][Full Text] [Related]
22. Characterization of O-polysaccharide specific monoclonal antibodies derived from mice infected with the rough Brucella melitensis strain B115. Cloeckaert A; Zygmunt MS; Dubray G; Limet JN J Gen Microbiol; 1993 Jul; 139(7):1551-6. PubMed ID: 7690392 [TBL] [Abstract][Full Text] [Related]
23. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants. Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039 [TBL] [Abstract][Full Text] [Related]
24. Inflammatory response of TLR4 deficient spleen macrophages (CRL 2471) to Brucella abortus S19 and an isogenic ΔmglA deletion mutant. Jacob J; Makou P; Finke A; Mielke M Int J Med Microbiol; 2016 May; 306(3):141-51. PubMed ID: 26946956 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of Brucella abortus vaccine strain RB51 compared to the reference vaccine Brucella abortus strain 19 in water buffalo. Caporale V; Bonfini B; Di Giannatale E; Di Provvido A; Forcella S; Giovannini A; Tittarelli M; Scacchia M Vet Ital; 2010; 46(1):13-9, 5-11. PubMed ID: 20391363 [TBL] [Abstract][Full Text] [Related]
26. Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model. Abadi AH; Mahdavi M; Khaledi A; Esmaeili SA; Esmaeili D; Sahebkar A Microb Pathog; 2018 Aug; 121():100-105. PubMed ID: 29709690 [TBL] [Abstract][Full Text] [Related]
27. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19. Elzer PH; Jacobson RH; Jones SM; Nielsen KH; Douglas JT; Winter AJ Immunology; 1994 Aug; 82(4):651-8. PubMed ID: 7835931 [TBL] [Abstract][Full Text] [Related]
28. Protection of mice against Brucella abortus infection by inoculation with monoclonal antibodies recognizing Brucella O-antigen. Phillips M; Deyoe BL; Canning PC Am J Vet Res; 1989 Dec; 50(12):2158-61. PubMed ID: 2481994 [TBL] [Abstract][Full Text] [Related]
29. A repA-based ELISA for discriminating cattle vaccinated with Brucella suis 2 from those naturally infected with Brucella abortus and Brucella melitensis. Wang JY; Wu N; Liu WH; Ren JJ; Tang P; Qiu YH; Wang CY; Chang CD; Liu HJ Mol Cell Probes; 2014; 28(5-6):251-4. PubMed ID: 24941369 [TBL] [Abstract][Full Text] [Related]
30. Unresponsiveness of vaccinated BALB/c mice to a second inoculation of lipopolysaccharide from Brucella abortus strain 2308. Pugh GW; Phillips M; Tabatabai LB; McDonald TJ Vet Microbiol; 1991 Jan; 26(1-2):167-77. PubMed ID: 1902610 [TBL] [Abstract][Full Text] [Related]
31. Immunization of Mice with Recombinant Brucella abortus Organic Hydroperoxide Resistance (Ohr) Protein Protects Against a Virulent Brucella abortus 544 Infection. Hop HT; Reyes AW; Simborio HL; Arayan LT; Min WG; Lee HJ; Lee JJ; Chang HH; Kim S J Microbiol Biotechnol; 2016 Jan; 26(1):190-6. PubMed ID: 26464379 [TBL] [Abstract][Full Text] [Related]
32. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization. Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469 [TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies to Brucella rough lipopolysaccharide: characterization and evaluation of their protective effect against B. abortus. Cloeckaert A; Jacques I; Bowden RA; Dubray G; Limet JN Res Microbiol; 1993; 144(6):475-84. PubMed ID: 7514802 [TBL] [Abstract][Full Text] [Related]
34. Protection against Brucella abortus in mice with O-polysaccharide-specific monoclonal antibodies. Montaraz JA; Winter AJ; Hunter DM; Sowa BA; Wu AM; Adams LG Infect Immun; 1986 Mar; 51(3):961-3. PubMed ID: 3005173 [TBL] [Abstract][Full Text] [Related]
37. A competitive enzyme immunoassay for the detection of bovine antibodies to Brucella abortus using monoclonal antibodies. Rylatt DB; Wyatt DM; Bundesen PG Vet Immunol Immunopathol; 1985 Feb; 8(3):261-71. PubMed ID: 3922105 [TBL] [Abstract][Full Text] [Related]
38. Brucella abortus in captive bison. I. Serology, bacteriology, pathogenesis, and transmission to cattle. Davis DS; Templeton JW; Ficht TA; Williams JD; Kopec JD; Adams LG J Wildl Dis; 1990 Jul; 26(3):360-71. PubMed ID: 2117675 [TBL] [Abstract][Full Text] [Related]
39. Comparison of T cell cytokines in resistant and susceptible mice infected with virulent Brucella abortus strain 2308. Fernandes DM; Jiang X; Jung JH; Baldwin CL FEMS Immunol Med Microbiol; 1996 Dec; 16(3-4):193-203. PubMed ID: 9116636 [TBL] [Abstract][Full Text] [Related]
40. Immunogenicity and protective effect of recombinant Brucella abortus Ndk (rNdk) against a virulent strain B. abortus 544 infection in BALB/c mice. Hop HT; Simborio HL; Reyes AW; Arayan LT; Min W; Lee HJ; Kim DH; Chang HH; Kim S FEMS Microbiol Lett; 2015 Feb; 362(4):. PubMed ID: 25724777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]